Corticosteroid licensed age indications and beclometasone diproprionate equivalence
| First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
|
Corticosteroid inhaler preparations, current licensed age indications (BTS SIGN guidelines June 2009). Current COPD licensed indications (BNF September 2011)
|
||||
|
|
UK License covers |
|||
|
Steroid |
>12 years |
5-12 years |
COPD license |
|
|
Beclometasone |
||||
|
Clenil Modulite |
√ |
√ |
√ |
χ |
|
Qvar |
√ |
χ |
χ |
χ |
|
Budesonide |
||||
|
Turbohaler |
√ |
√ |
χ |
χ |
|
Fluticasone |
||||
|
MDI (HFA) |
√ |
√ |
χ |
χ |
|
Accuhaler |
√ |
√ |
χ |
χ |
|
Combination products |
||||
|
Fostair |
Age 18 & over |
χ |
χ |
χ |
|
Symbicort |
√ |
Age 6 & over |
χ |
√ 200/6 & 400/12 |
|
Symbicort (regular & as required dosing) |
Age 18 & over |
χ |
χ |
χ |
|
Seretide MDI (HFA) |
√ |
√ |
χ |
χ |
|
Seretide Accuhaler** |
√ |
√ |
χ |
√ 500mcg |
Return to Chapter: 3. Respiratory System
Last updated by: on 05-10-2016 14:23
-
BNF
-
NICE
-
Summary of product characteristics
